| Symbol | BLSIF |
|---|---|
| Name | BRITANNIA LIFE SCIENCES INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | - |
| Address | M5H1T1 Canada ON 120 Adelaide St. West, Suite 2400 |
| Telephone | +1 416-433-9259 |
| Fax | — |
| — | |
| Website | https://britannia.life/ |
| Incorporation | — |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 3/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Canadian Securities Exchange |
| CIK | — |
| Description | Britannia Life Sciences Inc. is a global product development platform offering an integrated suite of products to assist companies along their product development journey. Britannias services, including product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations are offered to companies ranging from multinationals to startups particularly in the cosmetics, food and wellness industries. Britannia has garnered significant expertise in the development and regulatory approval of topical and edible cannabis products, including preparation and support for novel food authorizations. Additional info from OTC: |
No news found.